These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 28853185)

  • 1. A camelid nanobody against EGFR was easily obtained through refolding of inclusion body expressed in Escherichia coli.
    Xu L; Song X; Jia L
    Biotechnol Appl Biochem; 2017 Nov; 64(6):895-901. PubMed ID: 28853185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prokaryotic expression and refolding of EGFR extracellular domain and generation of phage display human scFv against EGFR.
    Zhou Y; Zhang J; Jin H; Chen Z; Wu Q; Li W; Yue M; Luo C; Wang M
    Biomed Pharmacother; 2013 Oct; 67(8):737-43. PubMed ID: 23639232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of dilution refolding conditions for a camelid single domain antibody against human beta-2-microglobulin.
    Bao X; Xu L; Lu X; Jia L
    Protein Expr Purif; 2016 Jan; 117():59-66. PubMed ID: 26386406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and characterization of humanized nanobodies targeting the dimer interface of epidermal growth factor receptor (EGFR).
    Zhu H; Zhao L; Li Z; Wen B; Qiu C; Liu M; Xu Z; Hu S; Li H
    Protein Expr Purif; 2019 May; 157():57-62. PubMed ID: 30735705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [On-column refolding and purification of human EGF receptor L2 domain inclusion body overexpressed in Escherichia coli].
    Xu LH; Hong A; He XH
    Sheng Wu Gong Cheng Xue Bao; 2005 Jul; 21(4):597-603. PubMed ID: 16176099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of a mono-biotinylated EGFR nanobody in the E. coli periplasm using the pET22b vector.
    Noor A; Walser G; Wesseling M; Giron P; Laffra AM; Haddouchi F; De Grève J; Kronenberger P
    BMC Res Notes; 2018 Oct; 11(1):751. PubMed ID: 30348204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study and evaluation of anti-EGFR nanobodies expressed in Pichia pastoris and Escherichia coli as antitumor moieties.
    Xi X; Sun W; Li H; Fan Q; Zhang X; Sun F
    Protein Expr Purif; 2021 Aug; 184():105888. PubMed ID: 33857600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and evaluation of a single domain antibody against human epidermal growth factor receptor (EGFR).
    Ahdi Khosroshahi S; Farajnia S; Ghiamirad M; Tanomand A; Veisi K; Rahbarnia L; Akbari B
    Protein Expr Purif; 2016 Apr; 120():59-64. PubMed ID: 26690373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo detection of small tumour lesions by multi-pinhole SPECT applying a (99m)Tc-labelled nanobody targeting the Epidermal Growth Factor Receptor.
    Krüwel T; Nevoltris D; Bode J; Dullin C; Baty D; Chames P; Alves F
    Sci Rep; 2016 Feb; 6():21834. PubMed ID: 26912069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformational nanobodies reveal tethered epidermal growth factor receptor involved in EGFR/ErbB2 predimers.
    Nevoltris D; Lombard B; Dupuis E; Mathis G; Chames P; Baty D
    ACS Nano; 2015 Feb; 9(2):1388-99. PubMed ID: 25603171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel recombinant immunotoxin of EGFR specific nanobody fused with cucurmosin, construction and antitumor efficiency in vitro.
    Deng C; Xiong J; Gu X; Chen X; Wu S; Wang Z; Wang D; Tu J; Xie J
    Oncotarget; 2017 Jun; 8(24):38568-38580. PubMed ID: 28445134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High affinity nanobodies against human epidermal growth factor receptor selected on cells by E. coli display.
    Salema V; Mañas C; Cerdán L; Piñero-Lambea C; Marín E; Roovers RC; Van Bergen En Henegouwen PM; Fernández LÁ
    MAbs; 2016 Oct; 8(7):1286-1301. PubMed ID: 27472381
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Piramoon M; Hosseinimehr SJ; Omidfar K; Noaparast Z; Abedi SM
    Chem Biol Drug Des; 2017 Apr; 89(4):498-504. PubMed ID: 27650045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a Recombinant Monospecific Anti-PLGF Bivalent Nanobody and Evaluation of it in Angiogenesis Modulation.
    Nikooharf A; Arezumand R; Mansouri K; Khoshi AH; Namdar Ahmadabad H
    Mol Biotechnol; 2020 Dec; 62(11-12):580-588. PubMed ID: 32975735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and purification of a toxin-linked conjugate targeting epidermal growth factor receptor in Escherichia coli.
    Ma C; Li Y; Li Z; Huang H; Xu K; Xu H; Bai J; Li X; Zhao G
    Protein Expr Purif; 2012 May; 83(1):1-7. PubMed ID: 22381467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production and Characterization of Novel Camel Single Domain Antibody Targeting Mouse Vascular Endothelial Growth Factor.
    Kazemi-Lomedasht F; Behdani M; Habibi-Anbouhi M; Shahbazzadeh D
    Monoclon Antib Immunodiagn Immunother; 2016 Jun; 35(3):167-71. PubMed ID: 27167350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant λ bacteriophage displaying nanobody towards third domain of HER-2 epitope inhibits proliferation of breast carcinoma SKBR-3 cell line.
    Shoae-Hassani A; Mortazavi-Tabatabaei SA; Sharif S; Madadi S; Rezaei-Khaligh H; Verdi J
    Arch Immunol Ther Exp (Warsz); 2013 Feb; 61(1):75-83. PubMed ID: 23224340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineering an anti-granulocyte colony stimulating factor receptor nanobody for improved affinity.
    Bakherad H; Farahmand M; Setayesh N; Ebrahim-Habibi A
    Life Sci; 2020 Sep; 257():118052. PubMed ID: 32634431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of three in-vitro refolding methods for human-derived anti-CTLA4 scFv expressed in E. coli].
    Huang Q; Chen L; Zeng L; Wan L; Li S; Lu X; Cheng J
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Apr; 23(2):388-91. PubMed ID: 16706373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the biodistribution and tumor targeting of two 99mTc-labeled anti-EGFR nanobodies in mice, using pinhole SPECT/micro-CT.
    Gainkam LO; Huang L; Caveliers V; Keyaerts M; Hernot S; Vaneycken I; Vanhove C; Revets H; De Baetselier P; Lahoutte T
    J Nucl Med; 2008 May; 49(5):788-95. PubMed ID: 18413403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.